Mother to Child HIV Transmission
|
|
- Felix Charles
- 5 years ago
- Views:
Transcription
1 Koff WC. NEJM 2010;363:e7 Mother to Child HIV Transmission Why We Still Need New Prevention Modalities Lynne M. Mofenson, M.D. Maternal and Pediatric Infectious Disease Branch Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health Department of Health and Human Services
2 Outline While there has been dramatic progress in development and implementation of effective interventions for PMTCT in the last 5 years, with current interventions we are unlikely to meet the goal of elimination by Briefly discuss PMTCT in US Current WHO guidelines Review progress on implementation Discuss why we still need new preventive interventions to reduce residual transmission and reach elimination goals
3 PMTCT Strategies in the US Universal prenatal HIV testing of all pregnant women Use of antiretroviral drugs during pregnancy to rapidly and durably suppress viral load Laboratory-guided, individualized patient management (HIV RNA, CD4) Infant antiretroviral prophylaxis Elective caesarean section (if RNA >1,000 c/ml) Replacement feeding
4 Number of HIV-Infected Infants and MTCT Rate in New York State by Year of Delivery, : N=475, MTCT ~25% Important to Note that in the US, Breastfeeding is NOT Recommended for HIV-Infected Women Source: AIDS Institute, New York State Department of Health, 2012
5 Effective Implementation Strategies in the US In addition to individualized care and not breastfeeding: 98% of women in US have antenatal care (90% HIVinfected women had antenatal care) 73% women in US start prenatal care in 1 st trimester, 21% 2 nd trimester 94% pregnant women receive HIV test 85% HIV-infected pregnant women received ARVs (pregnancy and/or IP) 96% HIV-exposed infants received ARV Enhanced Perinatal Surveillance System, US, Whitmore SK et al. Pediatrics 2012;129:e74-e Natality Public Use File CDC
6 2010 WHO Guidelines: Public Health Approach to PMTCT Shift to use of multi-drug efficacious regimens sd-nvp no longer recommended regimen Emphasized the importance of identifying and treating ART-eligible women Extended ARV coverage through duration of exposure Prophylaxis initiated at 14 wks ARV to mother or infant during breast feeding Endorsed breast feeding as preferred method with ARV coverage
7 Women Eligible for ART Are At Highest Risk for Mother to Child HIV Transmission and Mortality Kuhn L et al. AIDS 2010;24: Not Eligible 31.9% Eligible for ART Not eligible for ART MTCT by 6 wk 16.7% 5.0% Eligible 68.1% Proportion of MTCT by 6 wks 87.5% 12.5% MTCT after 6 wks 17.0% 4.2% 1,025 pregnant women and their infants in Zambia prior to HAART availability, followed for 24 mos Analyzed MTCT/mortality by eligibility for ART with current WHO criteria (CD4 <350 or WHO Stage 3 or 4) Proportion of MTCT after 6 wks Maternal mortality 24 mo post delivery 87.5% 12.5% 92% 8%
8 2010 WHO Guidelines Antenatal Early Late Postpartum Early Late Pregnancy 10-25% Full Option <28 wks A >28 vs wks B have not been compared 0-1 mo 1-6 in mos trial (there 6-24 mos is ~40-50% Option A Option B Starting 14 wks AZT + sdnvp (+ tail) Labor- Delivery 35-40% Breastfeeding 35-40% ongoing trial) Maternal but lifelong available ARV data Therapy indicate (CD4<350, both WHO Options 3, 4) have similar efficacy for PMTCT in women with high CD4: Time-Limited Provision of ARV Prophylaxis if CD4 >350 and WHO Stage 1/2 to Prevent MTCT In utero MTCT ~1.7% with maternal triple ARV vs AZT/sdNVP when maternal CD (Kesho Bora, devincenzi I et al. Lancet Inf Dis 2011;11:171-80) Daily Infant NVP x12 mos Postpartum MTCT ~2-3% with maternal triple ARV vs infant NVP when maternal CD4 >250 (BAN, Chasela C et al. NEJM 2010;362: ) Maternal Triple Drug Prophylaxis through 12 mos Infant ZDV or NVP for 4-6 wks
9 Lancet 2011;378:282-4 Proposed Option B+ : Life-Long ART for All Pregnant Women Antenatal Postpartum Early Late Early Late Pregnancy 10-25% Labor- Delivery 35-40% Breastfeeding 35-40% <28 wks >28 wks 0-1 mo 1-6 mos 6-24 mos Maternal Lifelong ARV Treatment (ART) for ALL HIV-Infected Pregnant Women
10 Benefits of Option B+ Antenatal Early Late Pregnancy 10-25% Labor- Delivery 35-40% Postpartum Early Late Breastfeeding 35-40% <28 wks >28 wks 0-1 mo 1-6 mos 6-24 mos OPTION B+ Maternal Lifelong ARV Treatment (ART) for ALL HIV-Infected Pregnant Women Easier to implement when CD4 availability limited and assures women who need ART get appropriate regimen Use of once daily TDF/3TC/EFV simplifies administration and harmonizes with adult recommendation Reduce MTCT Avoid stop-start with repeat pregnancies ( protection from conception for future pregnancies) Reduces sexual transmission in discordant partners, assuming good adherence and maintenance of viral suppression
11 Uncertainties of Option B+ Antenatal Postpartum Early Late Early Late Pregnancy 10-25% Labor- Delivery 35-40% Breastfeeding 35-40% <28 wks >28 wks 0-1 mo 1-6 mos 6-24 mos OPTION B+ Maternal Lifelong ARV Treatment (ART) for ALL HIV-Infected Pregnant Women Limited ARV safety data for TDF/EFV in pregnancy especially in populations with underlying malnutrition/comorbidities; conflicting data on triple ARV and preterm delivery Critical need to assure pharmacovigilance surveillance Acceptability and adherence Special attention needed - resistance if not adherent (and assumed benefits PMTCT and sexual tx will not accrue) Need for trained staff/task shifting from MDs to administer drugs Drug costs/equity
12 PMTCT Program Implementation in South Africa and Uganda
13 Cross-Sectional, Facility-Based Survey of National PMTCT Efficacy Using South Africa Immunization Clinics ( ) Dinh T-H et al th IAS Conference, Rome, Italy Abs.MoAC0206 Caregiver-infants wk old infant attending 1 st DPT (10,820) Caregiver-infants interviewed & infant-dbs* (9,915, 92%) Refused to participate, 84 (0.8%) No or insufficient infant-dbs 821 (7.6%) HIV not exposed, 6912 (69.7%) HIV-exposed (3,003; 30.3%) No PCR test result, 35 (1.2%) HIV-exposed infants with PCR test result (2,958; 98.5%) Inclusion: 4-8 wk/o attending clinic for 6 wk vaccine Exclusion: Severely ill infants needing emergency care
14 Weighted Perinatal (6 Week) MTCT, S Africa Dinh T-H et al th IAS Conference, Rome, Italy Abs.MoAC0206 Province Infant HIV Exposure % (95% CI) N= Wk Perinatal MTCT % (95% CI) Eastern Cape 30.0 ( ) 4.1 ( ) Free State 31.1 ( ) 6.0 ( ) Gauteng 30.2 ( ) 2.2 ( ) KwaZulu-Natal 43.9 ( ) 2.8 ( ) Limpopo 22.6 ( ) 3.5 ( ) Mpumalanga 36.2 ( ) 5.9 ( ) Northern Cape 15.6 ( ) 1.7 ( ) Northwest 30.9 ( ) 4.5 ( ) Western Cape 20.8 ( ) 3.3 ( ) National 31.4 ( ) 3.5% ( ) MTCT at age 6 wks without ARV 17-22%
15 PMTCT Implementation, Uganda HIV Prevalence In HIV-Exposed Infants <18 mos, Bannink-Mbazzi F et al. JAIDS 2013 (in press) CD4<200 ART CD4 >200 sdnvp CD4<200 ART CD4 >200 AZT+sdNVP+tail CD4<350 ART CD4 Option A infant NVP
16 Comparison 2008 and 2010 South Africa National PMTCT Guidelines Rundare A et al. 19 th CROI, Seattle, WA March 2012 (Abs 1003) In 2010, S. African guidelines implemented Option A (AZT/sdNVP + infant NVP) & ART with CD4 <350. 1,995 mother-infant pairs, June : 1147 (57.5%) in ANC before 2010 (AZT/sdNVP, no infant prophylaxis) 848 (42.5%) in ANC after 2010 (Option A) 6 week MTCT rates significantly lower with new guidelines: Historical MTCT at 6 weeks with no ARV: 17-22% Before new guidelines (AZT/sdNVP): 3.4% (95% CI %) After new guidelines (add infant NVP):1.5% (95% CI %)
17 Based on new PMTCT trials and implementation, WHO set a new goal to virtually eliminate new pediatric HIV infections and improve maternal survival by 2015
18 COUNTDOWN TO ZERO Global plan towards the elimination of new HIV infections among children and keeping their mothers alive. Global Target #1: Reduce the number of new HIV infections among children by 90% from 2009 baseline estimate By 2015, MTCT <5% in breastfeeding infants and new infections <40,000 by 2015 Global Target #2: Reduce the number of AIDS-related maternal deaths by 50%
19 If We Are Doing So Well, Why Do We Still Need New Prevention Modalities for PMTCT?
20 New Ped Infections Where are We in the Elimination Plan? Major Progress in PMTCT in Past Decade >100,000 HIV infections averted between (600,000 since 1995) 400, ,000 But we remain short of the goal of global elimination of MTCT 2011 In 2011, still 330,000 new pediatric HIV infections with ARV interventions 40, UNAIDS: World AIDS Day Report 2011
21 Virtual elimination is defined as MTCT <5% and 90% decrease in new infant infections to <40,000/year Even with optimal implementation, still anticipate residual transmission and significant numbers of new infections annually.
22 Elimination of MTCT Requires More than Just ARVs: New Perinatal HIV Infections, 25 Countries in the Year 2015: Virtual Elimination Goal <40,000 Perinatal Infections/Year and <5% MTCT , , ,000 MTCT 11% 95,000 MTCT 11% 72,000 MTCT 8% 0 No ARV for PMTCT 2009 ARV coverage (53% women reached) Mahy M et al. Sex Trans Infect 2010;86 Suppl 2:ii % ARV coverage 90% ARV coverage, AND HIV incidence women reduced by 50%, AND no unmet family planning 90% ARV coverage AND HIV incidence reduced by 50% AND no unmet family planning AND limit BF to 12 mos
23 Why Still Need New Prevention Modalities for PMTCT HIV testing still low; even if identified as HIV+, in 2011 only 63% of HIV+ women receive any ARV (57% effective ARV), 43% infants receive infant ARV prophylaxis % % % pregnant women receiving HIV test % HIV+ women receiving ARV prophylaxis 43% % HIV-exposed infants receiving ARV prophylaxis Adapted from WHO 2011 Global HIV/AIDS Update
24 ARV Coverage for PMTCT in Low- and Middle-Income Countries by Region, 2011 WHO 2012 Global HIV/AIDS Update
25 Continuing HIV Infections in Women of Childbearing Age HIV Prevalence (%) Among People15-24 Years Old, By Sex, Selected African Countries, Prevalence of HIV among young women in Sub- Saharan Africa is disproportionately higher than among young men than young women. In 2010, in sub-saharan Africa, 71% of people years old living with HIV were women. Together we will end AIDS. WHO 2012
26 New HIV Infections in Young Women WHO 2011 Global HIV/AIDS Update Among 24 high prevalence countries, since 2000, there is average 31% decline in HIV in pregnant women in antenatal clinics. The range, however, is wide from >50% increase to >70% decline. 7/24 had a >50% reduction. No decline in 5 others, including South Africa, with the largest HIV epidemic in the world. Botswana: , 46% decline
27 Women Continue to Be Infected In countries most affected by HIV, women of childbearing age continue to constitute 50% or more of HIV-infected individuals in Trends in Women Living with HIV Proportion of people age >15 years living with HIV who are female WHO 2011 Global HIV/AIDS Update
28 Why Still Need New Prevention Modalities for PMTCT Risk of HIV acquisition may be increased during pregnancy and HIV incidence in pregnancy in lowresource countries ranges between %. Country Reference Incidence per 100 Pt-Yrs Pregnancy Uganda Gray R et al. Lancet 2005;366: Botswana Lu L et al CROI Abs.94LB 1.3 ( ) Zimbabwe, Uganda South Africa Morrison CS et al. AIDS 2007;21:1027 Rehle T et al. S Afr Med J 2007;97: (0-12.9) South Africa Moodley D et al. AIDS 2009;23: ( )
29 Why Still Need New Prevention Modalities for PMTCT Risk of MTCT in infants of mothers with acute infection during pregnancy or lactation is increased ~3-fold over mothers with chronic HIV. Author Population Acute/recent HIV infection HIV Transmission to Infant Moodley D (JID 2011; 203:1231-4) 1,396 HIVwomen/48 3.4% seroconverted pregnancy or by 12 mo PP 2.3-fold higher risk of MTCT (Overall MTCT 20.5% acute vs 9.0% chronic HIV) Taha TE (AIDS 2011 May 21 epub) 2,561 HIV+ women (PP) 2.9% had recent infection 2.5-fold higher risk in utero MTCT (In utero MTCT 17.8% acute vs 6.7% chronic HIV) Humphrey (BMJ 2010;341: c6580) 11,240 HIVwomen 3.0% seroconverted postpartum 2.8-fold higher risk postnatal MTCT (Postnatal MTCT 23.6% acute vs 8.5% chronic HIV)
30 Antenatal Care Sub-Saharan Africa UNICEF: Antenatal care increasing in Sub-Saharan Africa, but less than half of women have minimum recommended 4 antenatal visits or have skilled birth attendant
31 Late Presentation for Antenatal Care Common While 75% of women in sub-saharan Africa have at least 1 antenatal visit, most are not seen until the 2 nd trimester (40%), and 32% not until 3 rd trimester. 4% 28% 40% 28% Sub-Saharan Africa
32 Time of Antenatal Care US vs Sub-Saharan Africa 73% of women in the US initiate care in 1 st trimester compared to 28% in Sub-Saharan Africa
33 For Maximal Efficacy, Early ARV Initiation Needed ARV Duration in Pregnancy and MTCT: - Johannesburg, S. Africa Hoffman R et al. JAIDS 2010;54:35-41 Group (873 pregnant women with advanced HIV infection; formula) % MTCT Overall group women all on HAART (N=873) (no sig. difference NVP vs LPV/r vs EFV regimen) 4.9% Duration of HAART during pregnancy: <4 weeks (N=151) 9.3% 4-16 weeks (N=422) 5.5% weeks (N=157) 3.5% In women starting HAART during pregnancy, each additional week of HAART reduced odds of transmission by 8% (adjusted OR 0.92, 95% CI )
34 No Maternal AP ARV Infants Why Not Give Infant HAART When the Mother Has Not Received Antepartum ARV: NICHD/HPTN 040 Study Birth <48h 2-4d 5-7d 2wk 6 wk 3 mo Arm 1 n=566 AZT x 6 wk Arm 2 n=562 AZT x 6 wk NVP NVP NVP Arm 3 n=556 AZT x 6 wk 3TC + Nefinavir x 2 wk 1684 Formula-Fed Infants from Brazil, S Africa, US infant HAART HIV Infection Status
35 % IP MTCT at 3 Mos NICHD/HPTN 040: IP MTCT Decreased by ~50% with Dual or Triple Infant ARV BUT Still Residual 2-3% Intrapartum Transmission Nielsen-Saines K et al. 18 th CROI, Boston, 2011 Abs 124LB Intrapartum Infection (HIV- at Birth, + after) K-M estimate 10.0% p=0.045 for comparison experimental arms to AZT control 8.0% 6.0% 4.9% More hematologic toxicity with 3 drug regimen 4.0% 2.2% 2.5% 2.0% 0.0% AZT AZT/NVP AZT/3TC/NFV # infants infected after birth with NVP resistance: 1 2 1
36 ART Adherence During Pregnancy and Postpartum Nachega J et al. AIDS 2012;26: Meta-analysis 51 studies in 20,153 pregnant women. Adequate adherence defined as >80% adherence to doses. Overall, only 73% reported >80% adherence. Antepartum 75.7 ( ) ( ) 9 Postpartum ZDV sdnvp cart % Adherence % Adherent (95% CI) No. Estimates 79.0 ( ) ( ) ( ) 28 Adherence was significantly worse in the postpartum period Adherence was also significantly worse in women receiving cart.
37 Survival Limiting Breastfeeding is Not An Option: Mortality and Weaning at 6 Months Kesho Bora Trial Cournil A et al. AIDS 2012 Dec (Epub ahead print) Within six months after birth, weaned or never breastfed children were at 7-fold higher risk of dying compared to children who were still breastfed - despite a context where interventions were provided to reduce risks associated with replacement feeding. Cause of Death by HIV & BF Status Uninfected HIV-Infected Wean/ no BF Still BF Wean/ no BF Still BF Gastro Pn Other Inf Malaria Other Total
38 Why Still Need New Prevention Modalities for PMTCT Breastfeeding needs to be prolonged even longer than 12 months to optimize infant health.. Diarrhea-Related Hospitalization or Death Among 618 HIV-Exposed Uninfected Infants by Actual Breastfeeding Practice and Age, ZEBS 3.2-fold increased risk (95% CI ) diarrhealhospitalizations or death between ages 4 and 24 months among infants who weaned vs those who continue to breastfeed Fawzy A et al. JID 2011;203:
39 Why Still Need New Prevention Modalities for PMTCT Even with maternal triple drug regimens, there is still residual postnatal transmission, particularly for infants of women presenting late in pregnancy or in labor (as in BAN). Overall HIV Transmission at 6 months Postnatal 2.9% 3.8% 3.1% 2.5% 1.0% 0.5% 0.5% MTCT (6wk-6mo)
40 Why Still Need New Prevention Modalities for PMTCT 12 month rates difficult to compare weaning varied; 99% weaned before 6 months in Mma Bana vs 68% BAN; lowest 12 mo rates (Mma Bana, Amata) are likely because infants not breastfeeding. Overall HIV Transmission at 12 months Note: Most stopped BF by 6 months Postnatal 4.5% 5.7% 3.9% 3.2% 1.8% 0.5% 0.5% MTCT (6wk-12mo)
41 Why Need New PMTCT Modalities? - Summary More than ARV are needed to reach virtual elimination goal (which is still 40,000 infections/year) Continuing infection in young women Acute HIV may be increased in pregnancy Increased infant transmission with acute infection Late presentation (common) reduces ARV efficacy for PMTCT Even if give infant HAART, still residual 2-3% intrapartum transmission in formula-fed infants (not accounting for BF) ART adherence particularly postpartum problematic For optimal infant survival need BF more than12 months Even with maternal ART, residual BM infection 1-4% at 6 months, 2-6% at 12 months
42 Conclusion: Why We Still Need New Prevention Modalities Women continue to become infected and even with optimized PMTCT interventions and achieving virtual elimination, still estimated to be 40,000 infected children born every year. Infants born to women with late HIV diagnosis at high transmission risk due to lack of antepartum drugs. Even with ARV prophylaxis, breast milk transmission occurs in a minimum 2-3% of infants by age 6-12 months. Yet for optimal infant survival need prolonged safe breastfeeding 18 months or more. Need intervention provides immediate protection and then provides prolonged protection through at least 2 years and does not rely on daily adherence to drugs.
43 Thanks For Your Attention
What s New in Prevention of Mother to Child HIV Transmission
Koff WC. NEJM 2010;363:e7 What s New in Prevention of Mother to Child HIV Transmission i And Why We Still Need an HIV Vaccine for Infants Lynne M Mofenson M D Lynne M. Mofenson, M.D. Pediatric, Adolescent
More informationInfant feeding in the ARV era. Department of Obstetrics and Gynaecology Faculty of Health Sciences and Tygerberg Hospital
Infant feeding in the ARV era Gerhard Theron Gerhard Theron Department of Obstetrics and Gynaecology Faculty of Health Sciences and Tygerberg Hospital Global HIV infections: 2007 12 countries account for
More informationAll HIV+ Women on Antiretroviral Therapy Should Breastfeed in Both Low and High Resource Settings VOTE NO!!
All HIV+ Women on Antiretroviral Therapy Should Breastfeed in Both Low and High Resource Settings VOTE NO!! Lynne Mofenson MD Elizabeth Glaser Pediatric AIDS Foundation My Esteemed Opponent Will Likely
More informationTOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV
TOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV Gladwel Muthoni KPA Conference 24 th April, 2018 OUTLINE Burden of HIV in PMTCT Mechanism and timing of Mother to Child Transmission (MTCT) Four
More informationInfant feeding and HIV Policy, Evidence and Hospital Challenges
Infant feeding and HIV Policy, Evidence and Hospital Challenges Max Kroon MMH/SCAH MY BRIEF Overview of infant feeding within the PMTCT program including national policy, feeding choices & research evidence
More informationElimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014
Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child
More informationScience roadmap on antiretroviral drugs for PMTCT and maternal treatment: current guidance, evidence in development and gaps
Appendix 4 Science roadmap on antiretroviral drugs for PMTCT and maternal treatment: current guidance, evidence in development and gaps Lynne M. Mofenson, MD Eunice Kennedy Shriver National Institute of
More informationhiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants
hiv/aids Programme Programmatic update Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants EXECUTIVE SUMMARY April 2012 EXECUTIVE SUMMARY Recent developments
More informationCUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA. Date
CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA 350 300 250 Number 200 150 100 50 0 1/01/1997 1/01/1998 1/01/1999 1/01/2000 31/12/2000 31/12/2001 31/12/2002 Date July 2004 Reported number of perinatally exposed
More informationDEPARTMENT. Treatment Recommendations for. Pregnant and Breastfeeding Women: Critical Issues Consolidated ARV Guidelines. Dr.
2013 Consolidated ARV Guidelines H I V / A I D S Treatment Recommendations for DEPARTMENT Pregnant and Breastfeeding Women: Critical Issues Dr. Nathan Shaffer Objectives of Presentation obackground ooverview
More informationElimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive:
Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive: Rationale for the call to action, progress to date and dealing with realities Rene Ekpini, MD, MPH Senior Adviser,
More informationThe promises & challenges of universal ART for women in southern Africa: Option B+ and beyond. Landon Myer
The promises & challenges of universal ART for women in southern Africa: Option B+ and beyond Landon Myer 6 th International Workshop on HIV & Women 21 February 2015 Overview 1) Background Where are we?
More informationUpdate on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines
WHO 2013 Consolidated ARV Guidelines Update on global guidelines H I V / A I D S DEPARTMENT and emerging issues on perinatal HIV prevention Children & HIV, St. Petersburg, Russia Sept 25-26, 2014 Dr. Nathan
More informationDr Graham P Taylor Reader in Communicable Diseases
HIV in Pregnancy Joint RCOG/BHIVA Multidisciplinary Conference Dr Graham Taylor Imperial College London Friday 20 January 2012, Royal College of Obstetricians and Gynaecologist, London Prevention of post-partum
More informationObjectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)
Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission
More informationEarly Antenatal (<36 weeks) Late Antenatal (36 weeks to labor) Early Antenatal (<36 weeks) Late Antenatal (36 weeks to labor)
Objectives Infant and Young Child Feeding in the Context of HIV/AIDS Nigel Rollins, MD Scientist Department of Maternal, Newborn, Child and Adolescent Health World Health Organization February 23, 218
More informationDr HM Sebitloane Chief Specialist (Outreach) Dept of O+G NRMSM
Dr HM Sebitloane Chief Specialist (Outreach) Dept of O+G NRMSM SA Background Population: 48m Annual number of deliveries:1,2m 97% of women attend the first ANC 71% of women attend 5 th ANC visit 97% of
More informationElijah Paintsil, MD, FAAP
Roadmap to elimination of mother-to-child transmission of HIV in Ghana by 2015 Towards HIV Free Generation Elijah Paintsil, MD, FAAP Assistant Professor of Pediatrics & Pharmacology Yale School of Medicine,
More informationBreast Feeding for Women with HIV?
Breast Feeding for Women with HIV? CHIVA / BHIVA Hermione Lyall Imperial Healthcare NHS Trust 17.11.17 Acknowledgements: Nell Freeman-Romilly, Pat Tookey, Claire Townsend, Claire Thorne, Kate Francis,
More information1. Africa Centre for Health and Population Studies 2. London School of Hygiene and Tropical Medicine 3. University College London
A systematic review of the effects of interrupted antiretroviral interventions for prevention of mother-to-child transmission of HIV on maternal disease progression and survival Naidu KK 1, Mori R 2, Newell
More informationPMTCT Max Kroon Mowbray Maternity Hospital Division of Neonatal Medicine School of Child and Adolescent Health University of Cape Town
PMTCT 2010 Max Kroon Mowbray Maternity Hospital Division of Neonatal Medicine School of Child and Adolescent Health University of Cape Town Prevention of Mother-To-Child Transmission of HIV or Prevention
More informationThe elimination equation: understanding the path to an AIDS-free generation
The elimination equation: understanding the path to an AIDS-free generation James McIntyre Anova Health Institute & School of Public Health & Family Medicine, University of Cape Town Elimination of perinatal
More informationXVII INTERNATIONAL AIDS CONFERENCE MEXICO CITY, 3-8 August 2008 SCALING-UP NATIONAL PMTCT PROGRAM
XVII INTERNATIONAL AIDS CONFERENCE MEXICO CITY, 3-8 August 2008 SCALING-UP NATIONAL PMTCT PROGRAM Phasing more efficacious ARV regimen for PMTCT in resource limited setting Lessons Learned from RWANDA
More informationProgress & challenges in PMTCT: The unfinished agenda
Progress & challenges in PMTCT: The unfinished agenda Dr Chewe Luo MMED (Paed); MTropPaed; PhD; FRCP Senior Adviser and Team Leader Country Programme Scale Up HIV Section, Programme Division UNICEF NY,
More informationThe Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT
The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT Peter McDermott Managing Director, CIFF 19 th Board meeting, Geneva 6 th May 2009 Investment Criteria Measurable...change
More informationImpact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines
Impact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines Thu-Ha Dinh, MD., MS., US CDC/GAP Ameena Goga, MD., MS., MRC/HSRU,
More informationMaking infant feeding safer progress and challenges in feeding and infant prophylaxis. Dr Lee Fairlie Priorities 2012
Making infant feeding safer progress and challenges in feeding and infant prophylaxis Dr Lee Fairlie Priorities 2012 To Breastfeed or Not To Breastfeed? The Balancing Act IATT October 2000 and 2006 recommendation:
More informationThe New National Guidelines. Feeding in the Context of HIV. Dr. Godfrey Esiru; National PMTCT Coordinator
The New National Guidelines (2010) for PMTCT and Infant Feeding in the Context of HIV Dr. Godfrey Esiru; National PMTCT Coordinator Presentation outline Evolution of the PMTCT guidelines in Uganda Rational
More informationOutline. Aim with PMTCT. How are children transmitted. Prevention of mother-to-child transmission of HIV. How does HIV transmit to children?
Prevention of mother-to-child transmission of HIV Outline AimofPMTCT How HIV is transmitted to children Epidemiology of HIV in children How to reduce HIV transmission to children Guidelines Lars T. Fadnes
More informationA Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia
ORIGINAL PAPER A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia Chibesa Shichitamba W, National Malaria Control Centre, Lusaka-Zambia ABSTRACT
More informationThe Cumulative Incidence of HIV Infection in HIVexposed Infants with a Birth Weight of 1500g Receiving Breast Milk and Daily Nevirapine
The Cumulative Incidence of HIV Infection in HIVexposed Infants with a Birth Weight of 1500g Receiving Breast Milk and Daily Nevirapine A retrospective, descriptive study conducted at Kalafong hospital,
More informationGlobal Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive
Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive DR. Nicholas Muraguri OGW, MD,MPH, MBA, PhD (c) Director, Global Plan Secretariat www.zero-hiv.org
More informationDECLINE IN POSITIVITY RATES AMONG HIV-EXPOSED INFANTS WITH CHANGES IN PMTCT ARV REGIMENS IN NIGERIA: EVIDENCE FROM 7 YEARS OF FIELD IMPLEMENTATION
Abst#_O_01 DECLINE IN POSITIVITY RATES AMONG HIV-EXPOSED INFANTS WITH CHANGES IN PMTCT ARV REGIMENS IN NIGERIA: EVIDENCE FROM 7 YEARS OF FIELD IMPLEMENTATION Hadiza Khamofu, 1 Edward Oladele, 1 Uche Ralph-Opara,
More informationUpdate on Option B+ Successes and Challenges. James McIntyre
Update on Option B+ Successes and Challenges James McIntyre Anova Health Institute & School of Public Health & Family Medicine, University of Cape Town Do not be fooled: People make simple things complex
More informationManagement of the HIV-Exposed Infant
Management of the HIV-Exposed Infant Katherine Knapp, MD Medical Director, Perinatal Program Department of Infectious Diseases St. Jude Children s Research Hospital Disclosures No conflicts of interest
More informationPregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20
Introduction Pregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20 Proportions HIV infections 19% amongst adolescents (- 29.5% nationally 15
More informationWhat will happen to these children?
The AIDS Epidemic: An Issue for Maternal and Child Health and Nutrition The AIDS Epidemic: An Issue for Maternal and Child Health and Nutrition Kathleen Rasmussen, PhD Professor, Division of Nutritional
More informationMedical and Ethical considera0ons/issues around Op0on B+ Anna Coutsoudis University of KwaZulu- Natal, South Africa
Medical and Ethical considera0ons/issues around Op0on B+ Anna Coutsoudis University of KwaZulu- Natal, South Africa Ethical Benefits Considerations of B+ 1. Easier implementation 2. Possibly lower horizontal
More informationAll HIV-exposed Infants Should Receive Triple Drug Antiretroviral Prophylaxis. Against the motion
All HIV-exposed Infants Should Receive Triple Drug Antiretroviral Prophylaxis Against the motion Hermione Lyall Imperial Healthcare NHS Trust, London, UK Acknowledgements: Pat Tookey, Ali Judd, Claire
More informationEmerging Issues in HIV and Pregnancy. Lynne M. Mofenson, MD. HIV Senior Technical Advisor Elizabeth Glaser Pediatric AIDS Foundation
Emerging Issues in HIV and Pregnancy Lynne M. Mofenson, MD HIV Senior Technical Advisor Elizabeth Glaser Pediatric AIDS Foundation Perinatal Transmission in the ART Era What s New? Antepartum ARV drug
More informationHIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI
HIV Infection in Pregnancy Francis J. Ndowa WHO RHR/STI FJN_STI_2005 Department of reproductive health and research Département santé et recherche génésiques Session outline Effect of pregnancy on HIV
More informationInfertility Treatment and HIV
Infertility Treatment and HIV Infertility Treatment by IVF Or Intra-cytoplasmic Sperm Injections (ICSC) In Chronic HIV-1 Sero- discordant Couples (Poster 670) Retrospective study of outcome of IVF or ICSC
More informationUsing new ARVs in pregnancy
Using new ARVs in pregnancy Dr Kerry Uebel Slides courtesy of Linda-Gail Bekker With thanks to CN Mnyani SA HIV Clinician s Society Meeting 5 August 2017 We have effective drugs. There is no reason why
More informationPREVENT TRANSMISSION OF HIV/AIDS PREGNANT WOMEN : LITERATUR REVIEW
PREVENT TRANSMISSION OF HIV/AIDS PREGNANT WOMEN : LITERATUR REVIEW *Nunung Nurhayati STIKep PPNI Jawa Barat, Bandung, West Java Indonesia Email: nunky_adzra@yahoo.com ABSTRACT Baby risk be infected HIV/AIDS
More informationDe la prévention à l élimination, le chemin parcouru en matière de transmission verticale. De la recherche aux recommandations OMS
De la prévention à l élimination, le chemin parcouru en matière de transmission verticale De la recherche aux recommandations OMS 16 novembre, 2011 Pr François DABIS Bordeaux 1985 1997 (1) 1985 1997 (1)
More informationTRANSMISSION OF HIV IN BREASTMILK
TRANSMISSION OF HIV IN BREASTMILK Ameena Goga Health Systems Research Unit, SA Medical Research Council Department of Paediatrics, University of Pretoria, SA SAHIV Clinicians Society Conference 24-27 October
More informationRevisiting Optimal Breast Feeding Durations: Modelling the impact of maternal ARV use and infant mortality
Revisiting Optimal Breast Feeding Durations: Modelling the impact of maternal ARV use and infant mortality Divya Mallampati, MD, MPH Rachel MacLean Andrea Ciaranello, MD, MPH World Health Organization
More informationHIV in the Next Generation: the Rocky Road to Elimination (focus on Africa)
REALITY HIV in the Next Generation: the Rocky Road to Elimination (focus on Africa) Medical Research Council Clinical Trials Unit at University College London Di Gibb Diana.gibb@ucl.ac.uk Outline Millennium
More informationPMTCT: A REVIEW OF THE PAST TWO YEARS AND THE WAY
PMTCT: A REVIEW OF THE PAST TWO YEARS AND THE WAY FORWARD. HOOSEN COOVADIA Victor Daitz Professor of HIV/AIDS Research University of KwaZulu-Natal, South Africa THE TERESA GROUP SYMPOSIUM. CHILDREN AND
More informationWHO s early release guidelines on PrEP: implications for emtct. Dominika Seidman, MD October 13, 2015
WHO s early release guidelines on PrEP: implications for emtct Dominika Seidman, MD October 13, 2015 Outline Evidence behind WHO early release guidelines on PrEP PrEP eligibility according to the WHO Rationale
More informationUsing new ARVs in pregnancy
Using new ARVs in pregnancy Linda-Gail Bekker With thanks to CN Mnyani SA HIV Clinician s Society Meeting 3 June 2017 We have effective drugs. There is no reason why any mother should die of AIDS. There
More informationObstetrics and HIV An Update. Jennifer Van Horn MD University of Utah
Obstetrics and HIV An Update Jennifer Van Horn MD University of Utah Obstetrics and HIV Perinatal transmission Testing Antiretroviral therapy Antepartum management Intrapartum management Postpartum management
More informationYoung Mothers: From pregnancy to early motherhood in adolescents with HIV
Young Mothers: From pregnancy to early motherhood in adolescents with HIV Lisa L. Abuogi, MD, MSc Assistant Professor University of Colorado, Denver 8 th HIV and Women Workshop March 2, 2018 Boston, MA
More informationUpdate on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012
PMTCT Update Update on PMTCT Margarett Davis, MD, MPH Chief, Maternal and Child Health Branch Division of Global HIV/AIDS Centers for Disease Control and Prevention (CDC) African Health Profession Regulatory
More informationPaediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff
Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State
More informationPeter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang 1
OUTCOMES OF HIV EXPOSED INFANTS BEFORE AND AFTER IMPLEMENTING OPTION B+ PMTCT GUIDELINE IN KAMPALA,UGANDA: A RETROSPECTIVE COHORT STUDY. Peter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang
More informationScientific and Programmatic Advances in PMTCT: To B or to B+?
Scientific and Programmatic Advances in PMTCT: To B or to B+? Roger Shapiro, MD, MPH Associate Professor of Medicine Harvard Medical School / Harvard School of Public Health Botswana-Harvard AIDS Institute
More informationAntiretroviral Therapy During Pregnancy and Delivery: 2015 Update
Frontier AIDS Education and Training Center Antiretroviral Therapy During Pregnancy and Delivery: 2015 Update Brian R. Wood, MD Assistant Professor of Medicine, University of Washington Medical Director,
More informationChallenges of HIV drug resistance in resource-limited settings
Challenges of HIV drug resistance in resource-limited settings Marie-Louise Newell Professor of Global Health Faculty of Medicine and Faculty of Social and Human Sciences, University of Southampton, UK
More informationScaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
More informationPrevention of Perinatal HIV Transmission
Prevention of Perinatal HIV Transmission Emily Adhikari, MD Division of Maternal-Fetal Medicine Obstetrics and Gynecology University of Texas Southwestern Medical Center February 20, 2018 None Understand
More informationAll [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON
All [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON Amy Slogrove Stellenbosch University 10 th International HIV Pediatrics Workshop
More informationPediatric Antiretroviral Therapy
Update on Pediatric Antiretroviral Therapy Lynne M. Mofenson, M.D. Pediatric, Adolescent and Maternal AIDS Branch National Institute of Child Health and Human Development National Institutes of Health
More informationUse of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH
Use of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH University of Pittsburgh Medical Center Disclosures Presenter has no financial interests to
More informationFigure S1: Overview of PMTCT Options A and B. Prevention of Mother to Child HIV Transmission (PMTCT)
Figure S1: Overview of PMTCT Options A and B Prevention of Mother to Child HIV Transmission (PMTCT) Option A: combined Antiretroviral therapy (ART) for all women meeting WHO 2010 criteria for initiation
More informationTo provide you with the basic concepts of HIV prevention using HIV rapid tests combined with counselling.
Module 2 Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs Purpose Pre-requisite Modules Learning Objectives To provide you with the basic concepts of HIV prevention using HIV rapid
More informationTHE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010
THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 The South African Antiretroviral Treatment Guidelines 2010 Goals of the programme Achieve best health outcomes in the most cost-efficient manner
More informationUsing new ARVs in pregnancy
Using new ARVs in pregnancy Dr Wendy Mphatswe SA HIV Clinician s Society Meeting 15 July 2017 Overview 1. HIV epidemic 2. HIV response (Fast Track) 3. Goal of therapy in pregnant and breastfeeding women
More informationCase Study: A Rapid Rollout of Universal Maternal HAART Improves Outcomes among HIV-Positive Women and Their Infants in Kenya
24 Case Study: A Rapid Rollout of Universal Maternal HAART Improves Outcomes among HIV-Positive Women and Their Infants in Kenya Maxwell Muganda, BScN, Jhpiego, APHIAPLUSKAMILI, Embu, Kenya Rosemary Njogu,
More informationCCC ARV Dosing Recommendations for HIV-exposed infants Updated
USERS NOTE: Please note this document does not provide guidance on overall decisionmaking regarding what medication(s) to use for HIV-exposed infants. This document is meant to facilitate ARV dosing for
More informationImproving UNAIDS paediatric and adolescent estimates
Improving UNAIDS paediatric and adolescent estimates BACKGROUND This document provides paediatric HIV programme managers with an overview of how paediatric and adolescent estimates are produced, what the
More informationPediatric HIV Infection and the Medical Management of Pregnant Women infected with HIV. Ernesto Parra, M.D., M.P.H.
Pediatric HIV Infection and the Medical Management of Pregnant Women infected with HIV Ernesto Parra, M.D., M.P.H. Adjunct Associate Professor UTHSCSA Department of Pediatrics and Family and Community
More informationWHAT S NEW IN THE 2015 PERINATAL HIV GUIDELINES?
WHAT S NEW IN THE 2015 PERINATAL HIV GUIDELINES? Today s Webinar will be starting soon For the audio portion of this meeting: Dial 1-855-702-5382 Enter participant code 596-825-4701# Guidelines for online
More informationHistoric Perspective on HIV and TB Research in Pregnant Women
Historic Perspective on HIV and TB Research in Pregnant Women Lynne M. Mofenson, M.D. Senior HIV Technical Advisor Elizabeth Glaser Pediatric AIDS Foundation High Burden of TB/HIV in Women - 2016 TB HIV
More informationMalaysian Consensus Guidelines on Antiretroviral Therapy Cheng Joo Thye Hospital Raja Permaisuri Bainun Ipoh
Malaysian Consensus Guidelines on Antiretroviral Therapy 2017 Cheng Joo Thye Hospital Raja Permaisuri Bainun Ipoh Acknowledgement Table of contents Evolution of when to initiate therapy ART improves survival
More informationLIMPOPO PROVINCIAL MEN S SECTORS/BROTHERS FOR LIFE
LIMPOPO PROVINCIAL MEN S SECTORS/BROTHERS FOR LIFE PRESENTED BY: RAPAKWANA JOHANNAH MANAGER:GAAP in HIV & AIDS & STIs Directorate DEPT OF HEALTH AND SOCIAL DEVELOPMENT VENUE: THE RANCH HOTEL DATE:09.03.2010
More informationEVIDENCE SUMMARIES OF INDIVIDUAL REPORTS IDENTIFIED THROUGH A SYSTEMATIC REVIEW
EVIDENCE SUMMARIES OF INDIVIDUAL REPORTS IDENTIFIED THROUGH A SYSTEMATIC REVIEW OF HIV-FREE SURVIVAL BY INFANT FEEDING PRACTICES FROM BIRTH TO 18 24 MONTHS T CHETTY KK NAIDU ML NEWELL 16 OCTOBER 2009 i
More informationMortality risk factors among HIV-exposed infants in rural and urban Cameroon
Tropical Medicine and International Health doi:10.1111/tmi.12424 volume 20 no 2 pp 170 176 february 2015 Mortality risk factors among HIV-exposed infants in rural and urban Cameroon Ragna S. Boerma 1,
More informationPAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist
PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical
More informationTB/HIV/STD Epidemiology and Surveillance Branch. First Annual Report, Dated 12/31/2009
TB/HIV/STD Epidemiology and Surveillance Branch First Annual Report, Dated 12/31/29 This Enhanced Perinatal Surveillance Report is the first annual report generated by the Texas Department of State Health
More informationUPTAKE OF THE PREVENTION OF MOTHER- TO-CHILD-TRANSMISSION PROGRAMME AT A PRIMARY CARE LEVEL IN SEDIBENG DISTRICT
UPTAKE OF THE PREVENTION OF MOTHER- TO-CHILD-TRANSMISSION PROGRAMME AT A PRIMARY CARE LEVEL IN SEDIBENG DISTRICT A Research Report Submitted to the Faculty of Health Sciences, University of the Witwatersrand
More informationMother-to-Child transmission of hiv and neonatal hiv ManageMent
Mother-to-Child transmission of hiv and neonatal hiv ManageMent Perinatal transmission of the human immunodeficiency virus (HIV), or mother-to-child transmission (MTCT), occurs when a mother living with
More informationPrevention of Mother-to-Child Transmission of HIV Infection
HIV Curriculum for the Health Professional Prevention of Mother-to-Child Transmission of HIV Infection Michael A. Tolle, MD, MPH Daniel Dewey, MD Objectives 1. Describe the scope of mother-to-child transmission
More informationHIV infection in pregnancy
HIV infection in pregnancy Peter Brocklehurst National Perinatal Epidemiology Unit, University of Oxford What is the size of the problem? in the population as a whole? in women? in pregnant women? in children?
More informationAdvances in HIV science and treatment. Report on the global AIDS epidemic,
HIV biomolecular advances and treatment updates David A Cooper National Centre in HIV Epidemiology and Clinical Research The University of New South Wales Sydney, Australia UNAIDS: global l HIV infections
More informationduring conception, pregnancy and lactation at 2 U.S. medical centers
Use of HIV preexposure prophylaxis during conception, pregnancy and lactation at 2 U.S. medical centers Dominika Seidman, MD Shannon Weber, Maria Teresa Timoney, Karishma Oza, Elizabeth Mullins, Rodney
More informationUsing Implementation Science to Address Prevention of Mother to Child Transmission of HIV
Using Implementation Science to Address Prevention of Mother to Child Transmission of HIV Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Founda@on 1 The role of Implementation
More informationSouth African goals and national policy
Connecting the dots for EMTCT A Decade of PMTCT South Africa has been one of the counties in sub-saharan Africa to be hard hit by the HIV virus. Despite this, the country did not implement its PMTCT programme
More informationA Call to Action Children The missing face of AIDS
A Call to Action Children The missing face of AIDS Scaling up Paediatric HIV Care Treatment in resource limited settings Dr Chewe Luo MMed(Paed); MTropPaed; PhD UNICEF Health Section Programme Division
More informationHIV, Women, & Pregnancy
HIV, Women, & Pregnancy Facts, Myths, and Management Nina K. Sublette, PhD, ACRN, AACRN, FNP University of Tennessee Department of Obstetrics and Gynecology St. Jude Children s Research Hospital Department
More informationMalawi s Option B+ Key Considerations & Progress
Malawi s Option B+ Key Considerations & Progress HIV in Malawi 16 million population 1.1 million HIV population 10% adult HIV prevalence High rural burden 26,000 AIDS deaths 63,000 HIV+ pregn. women 5.7
More informationtreatment during pregnancy and breastfeeding
treatment during pregnancy and breastfeeding Topics covered Introduction. Preventing parent-to-child transmission. AZT as a single therapy. Treatment begun late in pregnancy. Nevirapine for mothers and
More informationCROI 2016 Update NEAETC, March 21, Sigal Yawetz, MD Brigham and Women s Hospital Harvard Medical School
CROI 2016 Update NEAETC, March 21, 2016 Sigal Yawetz, MD Brigham and Women s Hospital Harvard Medical School CROI 2016 Update NEAETC, March 21, 2016 UNITED STATES EPIDEMIOLOGY Estimating the lifetime risk
More informationThe global plan to eliminate mother to child transmission (emtct) of HIV: challenges in integration and of therapeutic strategies
Training Course in Sexual and Reproductive Health Research 2014 Module: Principles and Practice of Sexually Transmitted Infections Prevention and Care The global plan to eliminate mother to child transmission
More informationFAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030
Evidence informed, responsive and sustainable care FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030 Alti Zwandor UNAIDS Country Director Maseru, Lesotho 9 December
More informationCopyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN
UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of
More informationLabor & Delivery Management for Women Living with HIV. Pooja Mittal, DO Lisa Rahangdale, MD
Labor & Delivery Management for Women Living with HIV Pooja Mittal, DO Lisa Rahangdale, MD Statistics for Perinatally Acquired HIV Timing of Perinatal HIV Transmission Most transmission occurs close to
More informationWhy Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV?
Why Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV? Epidemiology of HIV in Adolescent & Young Women Lynne M. Mofenson MD Elizabeth Glaser Pediatric AIDS Foundation
More informationPMTCT UPDATE. AWACC CONFERENCE DURBAN SEPT 2013 Dr HM Sebitloane Chief Specialist, Dept of O+G, NRMSM
PMTCT UPDATE AWACC CONFERENCE DURBAN SEPT 2013 Dr HM Sebitloane Chief Specialist, Dept of O+G, NRMSM Outline Background Risk of MTCT Historical ARV interventions SA PMTCT program Rationale for changes
More informationPregnancy and HIV. Dr Annemiek de Ruiter. September 2009
Pregnancy and HIV Dr Annemiek de Ruiter September 2009 NSHPC NSHPC update, October 2008 Obstetric and paediatric HIV surveillance data from the UK and Ireland National Study of HIV in Pregnancy and Childhood
More information